N. Avasthy

Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study.

J. Brachmann, J. Reiber, M. Krucoff, 2006, European heart journal.